Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Definitive Healthcare (DH) EPS (Weighted Average and Diluted) (2021 - 2025)

Definitive Healthcare's EPS (Weighted Average and Diluted) history spans 5 years, with the latest figure at -$0.1 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 80.77% year-over-year to -$0.1; the TTM value through Dec 2025 reached -$1.26, up 64.31%, while the annual FY2025 figure was -$1.3, 63.28% up from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.1 in Q4 2025 per DH's latest filing, up from -$0.14 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.06 in Q4 2022 to a low of -$1.81 in Q2 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.38, with a median of -$0.1 recorded in 2021.
  • Peak YoY movement for EPS (Weighted Average and Diluted): surged 154.55% in 2022, then tumbled 4900.0% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.11 in 2021, then surged by 154.55% to $0.06 in 2022, then plummeted by 216.67% to -$0.07 in 2023, then plummeted by 642.86% to -$0.52 in 2024, then surged by 80.77% to -$0.1 in 2025.
  • Per Business Quant, the three most recent readings for DH's EPS (Weighted Average and Diluted) are -$0.1 (Q4 2025), -$0.14 (Q3 2025), and -$0.07 (Q2 2025).